Literature DB >> 10728378

Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis.

H Perlman1, M Sata, K Krasinski, T Dorai, R Buttyan, K Walsh.   

Abstract

OBJECTIVE: The balance between apoptosis and cell proliferation is vital for cellular homeostasis, yet little is known about the mechanisms that coordinate these two cell fates, particularly in the vessel wall. It is well established that the members of Bcl-2-gene family are regulators of apoptosis, but their role in cellular proliferation is less clear.
METHODS: We analyzed the effects of disrupting Bcl-2 expression in vascular smooth muscle cells (VSMCs) by adenoviral-mediated delivery of a hammerhead ribozyme against bcl-2 mRNA (Ad-Rbz-Bcl-2).
RESULTS: Forced ablation of Bcl-2 in balloon-injured rat carotid arteries reduced cell number and inhibited neointimal hyperplasia. In vitro, VSMCs transduced with the Ad-Rbz-Bcl-2 underwent apoptosis as indicated by a reduction in cell number and DNA fragmentation. Ad-Rbz-Bcl-2-transduced cells also exhibited aberrations in both G1- and S-phases of the cell cycle. However, forced perturbations in cell cycle activity by serum-stimulation or treatment with chemical inhibitors did not affect Ad-Rbz-Bcl-2-induced cell death, indicating that these cell cycle changes are not essential for apoptosis.
CONCLUSION: These data show that physiological levels of Bcl-2 are essential for VSMC viability and that ablation of Bcl-2 alters cell cycle activity through the execution of the apoptotic process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728378     DOI: 10.1016/s0008-6363(99)00346-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  A selection system for identifying accessible sites in target RNAs.

Authors:  W H Pan; H F Devlin; C Kelley; H C Isom; G A Clawson
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

2.  Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.

Authors:  Toshimitsu Suhara; Hyo-Soo Kim; Lorrie A Kirshenbaum; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 3.  Metabolic Stress.

Authors:  Isabella M Grumbach; Emily K Nguyen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

4.  Magnolol induces apoptosis in vascular smooth muscle.

Authors:  Jiun-Han Chen; Chin-Chen Wu; George Hsiao; Mao-Hsiung Yen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-25       Impact factor: 3.000

5.  WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Bing-Qi Li; Shuai Huang; Qian-Qian Shao; Jian Sun; Li Zhou; Lei You; Tai-Ping Zhang; Quan Liao; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

6.  TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.

Authors:  X Shi; L-W Guo; S M Seedial; Y Si; B Wang; T Takayama; P A Suwanabol; S Ghosh; D DiRenzo; B Liu; K C Kent
Journal:  Cell Death Dis       Date:  2014-07-10       Impact factor: 8.469

7.  Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: role in neointimal formation after vascular injury.

Authors:  Takashi Ashino; Masayuki Yamamoto; Satoshi Numazawa
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

Review 8.  The protective effect of bee venom on fibrosis causing inflammatory diseases.

Authors:  Woo-Ram Lee; Sok Cheon Pak; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2015-11-16       Impact factor: 4.546

9.  Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model.

Authors:  Jin Hee Kim; Gha Young Lee; Hyo Jin Maeng; Hoyoun Kim; Jae Hyun Bae; Kyoung Min Kim; Soo Lim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.